Downloads: 3 | Views: 99 | Weekly Hits: ⮙3 | Monthly Hits: ⮙3
Analysis Study Research Paper | Ophthalmology | India | Volume 12 Issue 4, April 2023 | Rating: 5.4 / 10
A Study on used of Low Dose Aspirin for the Treatment of Central Serous Chorioretinopathy
Dr. Arvind Kumar Tiwari | Dr. Jigyasa Srivastava
Abstract: Background: Central serous chorioretinopathy is an important ophthalmological morbidity. This study was mainly undertaken in order to assess the efficacy of low dose aspirin in treatment of central serous chorioretinopathy. Material and Methods: A randomized controlled trial was undertaken in a tertiary care hospital in sixty cases who was equally divided in to two groups. Treatment group received 75 mg of low dose aspirin daily and placebo received no treatment. The patients were followed up for a period of six months with Visual acuity by using Snellen chart and log MAR vision. The recurrence was also noted at the end of follow up. Results: There was no significant difference in age and sex between the low dose aspirin group and placebo group. The improvement in visual acuity was noted in both the groups but more evident in the low dose aspirin group at the end of six months of follow up. The log MAR vision had also shown more improvement in the low dose aspirin than placebo group. The rate of recurrences was lower in the low dose aspirin group than the placebo group. Conclusion: The low dose aspirin had shown beneficial effect in patients with central serous chorioretinopathy.
Keywords: Central serous chorioretinopathy, Low dose aspirin, Visual acuity, Log MAR vision, recurrence
Edition: Volume 12 Issue 4, April 2023,
Pages: 659 - 661